FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:PTEN-HECTD2

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: PTEN-HECTD2
FusionPDB ID: 69914
FusionGDB2.0 ID: 69914
HgeneTgene
Gene symbol

PTEN

HECTD2

Gene ID

5728

143279

Gene namephosphatase and tensin homologHECT domain E3 ubiquitin protein ligase 2
Synonyms10q23del|BZS|CWS1|DEC|GLM2|MHAM|MMAC1|PTEN1|PTENbeta|TEP1-
Cytomap

10q23.31

10q23.32

Type of geneprotein-codingprotein-coding
Descriptionphosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTENMMAC1 phosphatase and tensin homolog deleted on chromosome 10PTENepsilonmitochondrial PTENalphamitochondrial phosphatase and tensin protein alphamutatprobable E3 ubiquitin-protein ligase HECTD2HECT domain containing E3 ubiquitin protein ligase 2HECT domain-containing protein 2HECT-type E3 ubiquitin transferase HECTD2
Modification date2020032920200313
UniProtAcc.

Q5U5R9

Main function of 5'-partner protein: FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. {ECO:0000269|PubMed:28584101}.; FUNCTION: (Microbial infection) Catalyzes ubiquitination of Botulinum neurotoxin A light chain (LC) of C.botulinum neurotoxin type A (BoNT/A). {ECO:0000269|PubMed:28584101}.
Ensembl transtripts involved in fusion geneENST idsENST00000371953, ENST00000472832, 
ENST00000498446, ENST00000371667, 
ENST00000536715, ENST00000298068, 
ENST00000371681, ENST00000446394, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score32 X 22 X 15=105605 X 6 X 6=180
# samples 427
** MAII scorelog2(42/10560*10)=-4.65207669657969
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(7/180*10)=-1.36257007938471
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: PTEN [Title/Abstract] AND HECTD2 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: PTEN [Title/Abstract] AND HECTD2 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)PTEN(89624381)-HECTD2(93260259), # samples:1
PTEN(89653866)-HECTD2(93244264), # samples:1
Anticipated loss of major functional domain due to fusion event.PTEN-HECTD2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
PTEN-HECTD2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
PTEN-HECTD2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
PTEN-HECTD2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgenePTEN

GO:0001933

negative regulation of protein phosphorylation

20123964

HgenePTEN

GO:0006470

protein dephosphorylation

9256433

HgenePTEN

GO:0008285

negative regulation of cell proliferation

19057511

HgenePTEN

GO:0045736

negative regulation of cyclin-dependent protein serine/threonine kinase activity

21241890

HgenePTEN

GO:0046855

inositol phosphate dephosphorylation

9593664

HgenePTEN

GO:0046856

phosphatidylinositol dephosphorylation

9593664|9811831

HgenePTEN

GO:0050821

protein stabilization

20123964

HgenePTEN

GO:0060070

canonical Wnt signaling pathway

20123964

HgenePTEN

GO:1902807

negative regulation of cell cycle G1/S phase transition

10918569

HgenePTEN

GO:1904668

positive regulation of ubiquitin protein ligase activity

21241890

HgenePTEN

GO:2000060

positive regulation of ubiquitin-dependent protein catabolic process

21241890

HgenePTEN

GO:2000134

negative regulation of G1/S transition of mitotic cell cycle

21241890



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr10:89624381/chr10:93260259)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across PTEN (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across HECTD2 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000371953PTENchr1089653866+ENST00000446394HECTD2chr1093244264+540815215563030824

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000371953ENST00000446394PTENchr1089653866+HECTD2chr1093244264+0.0003213740.9996786

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for PTEN-HECTD2

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
PTENchr1089653866HECTD2chr10932442641521321LEGVYRNNIDDVVRLSQKRFKQLVER

Top

Potential FusionNeoAntigen Information of PTEN-HECTD2 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
PTEN-HECTD2_89653866_93244264.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
PTEN-HECTD2chr1089653866chr10932442641521HLA-A66:01DVVRLSQKR0.99680.5121019
PTEN-HECTD2chr1089653866chr10932442641521HLA-A26:03DVVRLSQKR0.98280.5561019
PTEN-HECTD2chr1089653866chr10932442641521HLA-A66:03DVVRLSQKR0.65470.5041019
PTEN-HECTD2chr1089653866chr10932442641521HLA-A68:24DDVVRLSQKR0.83120.6265919
PTEN-HECTD2chr1089653866chr10932442641521HLA-A68:03DDVVRLSQKR0.81140.6144919
PTEN-HECTD2chr1089653866chr10932442641521HLA-B27:02YRNNIDDVVRL10.6698415
PTEN-HECTD2chr1089653866chr10932442641521HLA-B27:04YRNNIDDVVRL10.855415
PTEN-HECTD2chr1089653866chr10932442641521HLA-B27:05YRNNIDDVVRL10.9124415
PTEN-HECTD2chr1089653866chr10932442641521HLA-B39:01YRNNIDDVVRL0.99980.7821415
PTEN-HECTD2chr1089653866chr10932442641521HLA-B38:01YRNNIDDVVRL0.99960.9383415
PTEN-HECTD2chr1089653866chr10932442641521HLA-B38:02YRNNIDDVVRL0.99960.9491415
PTEN-HECTD2chr1089653866chr10932442641521HLA-C04:10NIDDVVRL10.604715
PTEN-HECTD2chr1089653866chr10932442641521HLA-C08:15NIDDVVRL10.9065715
PTEN-HECTD2chr1089653866chr10932442641521HLA-C05:09NIDDVVRL10.8615715
PTEN-HECTD2chr1089653866chr10932442641521HLA-C04:07NIDDVVRL10.6078715
PTEN-HECTD2chr1089653866chr10932442641521HLA-C04:14NIDDVVRL0.99810.6088715
PTEN-HECTD2chr1089653866chr10932442641521HLA-C04:06NIDDVVRL0.99710.7073715
PTEN-HECTD2chr1089653866chr10932442641521HLA-B27:14VRLSQKRFK0.99540.84691221
PTEN-HECTD2chr1089653866chr10932442641521HLA-A68:01DDVVRLSQKR0.83120.6265919
PTEN-HECTD2chr1089653866chr10932442641521HLA-C07:05YRNNIDDVVRL0.99990.8716415
PTEN-HECTD2chr1089653866chr10932442641521HLA-C07:67YRNNIDDVVRL0.99990.8997415
PTEN-HECTD2chr1089653866chr10932442641521HLA-C07:46YRNNIDDVVRL0.99990.7657415
PTEN-HECTD2chr1089653866chr10932442641521HLA-C07:13YRNNIDDVVRL0.99990.8857415
PTEN-HECTD2chr1089653866chr10932442641521HLA-C07:27YRNNIDDVVRL0.99990.9218415
PTEN-HECTD2chr1089653866chr10932442641521HLA-C07:19YRNNIDDVVRL0.99990.6173415
PTEN-HECTD2chr1089653866chr10932442641521HLA-C07:95YRNNIDDVVRL0.99990.6928415
PTEN-HECTD2chr1089653866chr10932442641521HLA-C07:29YRNNIDDVVRL0.99990.9475415
PTEN-HECTD2chr1089653866chr10932442641521HLA-C07:80YRNNIDDVVRL0.99990.8997415
PTEN-HECTD2chr1089653866chr10932442641521HLA-C07:10YRNNIDDVVRL0.99990.9458415
PTEN-HECTD2chr1089653866chr10932442641521HLA-B27:03YRNNIDDVVRL0.99890.9283415
PTEN-HECTD2chr1089653866chr10932442641521HLA-C12:16YRNNIDDVVRL0.9970.9692415
PTEN-HECTD2chr1089653866chr10932442641521HLA-C04:01NIDDVVRL10.6078715
PTEN-HECTD2chr1089653866chr10932442641521HLA-C05:01NIDDVVRL10.8615715
PTEN-HECTD2chr1089653866chr10932442641521HLA-C18:01NIDDVVRL10.6147715
PTEN-HECTD2chr1089653866chr10932442641521HLA-C08:02NIDDVVRL10.9065715
PTEN-HECTD2chr1089653866chr10932442641521HLA-C04:03NIDDVVRL10.6378715
PTEN-HECTD2chr1089653866chr10932442641521HLA-B27:10VRLSQKRFK0.99740.85811221
PTEN-HECTD2chr1089653866chr10932442641521HLA-B15:24VVRLSQKRF0.89860.79321120
PTEN-HECTD2chr1089653866chr10932442641521HLA-A25:01DVVRLSQKRF0.98540.90151020
PTEN-HECTD2chr1089653866chr10932442641521HLA-B27:06YRNNIDDVVRL10.8423415
PTEN-HECTD2chr1089653866chr10932442641521HLA-B27:08YRNNIDDVVRL10.8508415
PTEN-HECTD2chr1089653866chr10932442641521HLA-B27:09YRNNIDDVVRL10.9216415
PTEN-HECTD2chr1089653866chr10932442641521HLA-B27:10YRNNIDDVVRL10.9245415
PTEN-HECTD2chr1089653866chr10932442641521HLA-C07:01YRNNIDDVVRL0.99990.6418415
PTEN-HECTD2chr1089653866chr10932442641521HLA-B39:31YRNNIDDVVRL0.99990.7854415
PTEN-HECTD2chr1089653866chr10932442641521HLA-C07:02YRNNIDDVVRL0.99990.8997415
PTEN-HECTD2chr1089653866chr10932442641521HLA-C06:08YRNNIDDVVRL0.99980.9909415
PTEN-HECTD2chr1089653866chr10932442641521HLA-B38:05YRNNIDDVVRL0.99960.9383415
PTEN-HECTD2chr1089653866chr10932442641521HLA-C07:22YRNNIDDVVRL0.99940.7412415
PTEN-HECTD2chr1089653866chr10932442641521HLA-C06:02YRNNIDDVVRL0.99380.9949415
PTEN-HECTD2chr1089653866chr10932442641521HLA-C06:17YRNNIDDVVRL0.99380.9949415

Top

Potential FusionNeoAntigen Information of PTEN-HECTD2 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
PTEN-HECTD2_89653866_93244264.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
PTEN-HECTD2chr1089653866chr10932442641521DRB1-0820YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-0820RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-0828YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-0828RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1104YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1104RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1106YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1106RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1118YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1118RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1125YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1125RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1135YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1135RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1138YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1138RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1142YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1142RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1143YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1143RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1144YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1144RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1146YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1146RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1147YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1147RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1150YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1150RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1154YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1154RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1156YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1156RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1157YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1157RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1158YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1158RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1160YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1160RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1167YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1167RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1177YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1177RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1178YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1178RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1183YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1184YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1184RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1188YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1188RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1201NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1201IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1201NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1201DDVVRLSQKRFKQLV924
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1203NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1203IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1203NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1203DDVVRLSQKRFKQLV924
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1204NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1204IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1204NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1205NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1205IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1205NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1205DDVVRLSQKRFKQLV924
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1206NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1206IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1206NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1206DDVVRLSQKRFKQLV924
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1207NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1207IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1207NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1207DDVVRLSQKRFKQLV924
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1208NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1208IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1208NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1208DDVVRLSQKRFKQLV924
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1209NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1209IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1209NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1210NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1210IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1210NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1210DDVVRLSQKRFKQLV924
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1211NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1211IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1211NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1211DDVVRLSQKRFKQLV924
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1212NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1212IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1212NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1212DDVVRLSQKRFKQLV924
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1213NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1213IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1213NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1213DDVVRLSQKRFKQLV924
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1214NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1214IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1214NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1214DDVVRLSQKRFKQLV924
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1215NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1215IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1215NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1215DDVVRLSQKRFKQLV924
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1216NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1216IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1216NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1217NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1217IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1217NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1217DDVVRLSQKRFKQLV924
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1218NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1218IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1218NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1218DDVVRLSQKRFKQLV924
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1219NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1219IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1219NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1219DDVVRLSQKRFKQLV924
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1220NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1220IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1220NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1220DDVVRLSQKRFKQLV924
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1221NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1221IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1221NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1221DDVVRLSQKRFKQLV924
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1222NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1222IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1223NIDDVVRLSQKRFKQ722
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1223IDDVVRLSQKRFKQL823
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1223NNIDDVVRLSQKRFK621
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1223DDVVRLSQKRFKQLV924
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1306YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1306RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1311YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1311RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1318YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1318RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1342YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1342RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1433YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1433RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1484YRNNIDDVVRLSQKR419
PTEN-HECTD2chr1089653866chr10932442641521DRB1-1484RNNIDDVVRLSQKRF520
PTEN-HECTD2chr1089653866chr10932442641521DRB3-0209EGVYRNNIDDVVRLS116
PTEN-HECTD2chr1089653866chr10932442641521DRB3-0209LEGVYRNNIDDVVRL015
PTEN-HECTD2chr1089653866chr10932442641521DRB3-0212EGVYRNNIDDVVRLS116
PTEN-HECTD2chr1089653866chr10932442641521DRB3-0213EGVYRNNIDDVVRLS116
PTEN-HECTD2chr1089653866chr10932442641521DRB3-0213LEGVYRNNIDDVVRL015
PTEN-HECTD2chr1089653866chr10932442641521DRB3-0216EGVYRNNIDDVVRLS116
PTEN-HECTD2chr1089653866chr10932442641521DRB3-0216LEGVYRNNIDDVVRL015
PTEN-HECTD2chr1089653866chr10932442641521DRB3-0219EGVYRNNIDDVVRLS116
PTEN-HECTD2chr1089653866chr10932442641521DRB3-0221EGVYRNNIDDVVRLS116
PTEN-HECTD2chr1089653866chr10932442641521DRB3-0221LEGVYRNNIDDVVRL015
PTEN-HECTD2chr1089653866chr10932442641521DRB3-0222EGVYRNNIDDVVRLS116
PTEN-HECTD2chr1089653866chr10932442641521DRB3-0303EGVYRNNIDDVVRLS116

Top

Fusion breakpoint peptide structures of PTEN-HECTD2

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
6286NNIDDVVRLSQKRFPTENHECTD2chr1089653866chr10932442641521

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of PTEN-HECTD2

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN6286NNIDDVVRLSQKRF-7.36978-7.48318
HLA-B14:023BVN6286NNIDDVVRLSQKRF-4.19173-5.22703
HLA-B52:013W396286NNIDDVVRLSQKRF-6.08078-7.11608
HLA-B52:013W396286NNIDDVVRLSQKRF-6.02808-6.14148
HLA-A11:014UQ26286NNIDDVVRLSQKRF-11.396-11.5094
HLA-A24:025HGA6286NNIDDVVRLSQKRF-5.5142-6.5495
HLA-A24:025HGA6286NNIDDVVRLSQKRF-5.43263-5.54603
HLA-B27:056PYJ6286NNIDDVVRLSQKRF-5.93836-6.05176
HLA-B44:053DX86286NNIDDVVRLSQKRF-5.39102-5.50442
HLA-B44:053DX86286NNIDDVVRLSQKRF-4.5657-5.601

Top

Vaccine Design for the FusionNeoAntigens of PTEN-HECTD2

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
PTEN-HECTD2chr1089653866chr10932442641019DVVRLSQKRTGTAGTAAGATTGTCCCAGAAGAGGTT
PTEN-HECTD2chr1089653866chr10932442641020DVVRLSQKRFTGTAGTAAGATTGTCCCAGAAGAGGTTCAA
PTEN-HECTD2chr1089653866chr10932442641120VVRLSQKRFAGTAAGATTGTCCCAGAAGAGGTTCAA
PTEN-HECTD2chr1089653866chr10932442641221VRLSQKRFKAAGATTGTCCCAGAAGAGGTTCAAACA
PTEN-HECTD2chr1089653866chr1093244264415YRNNIDDVVRLCAGGAACAATATTGATGATGTAGTAAGATTGTC
PTEN-HECTD2chr1089653866chr1093244264715NIDDVVRLTATTGATGATGTAGTAAGATTGTC
PTEN-HECTD2chr1089653866chr1093244264919DDVVRLSQKRTGATGTAGTAAGATTGTCCCAGAAGAGGTT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
PTEN-HECTD2chr1089653866chr1093244264015LEGVYRNNIDDVVRLTGAAGGCGTATACAGGAACAATATTGATGATGTAGTAAGATTGTC
PTEN-HECTD2chr1089653866chr1093244264116EGVYRNNIDDVVRLSAGGCGTATACAGGAACAATATTGATGATGTAGTAAGATTGTCCCA
PTEN-HECTD2chr1089653866chr1093244264419YRNNIDDVVRLSQKRCAGGAACAATATTGATGATGTAGTAAGATTGTCCCAGAAGAGGTT
PTEN-HECTD2chr1089653866chr1093244264520RNNIDDVVRLSQKRFGAACAATATTGATGATGTAGTAAGATTGTCCCAGAAGAGGTTCAA
PTEN-HECTD2chr1089653866chr1093244264621NNIDDVVRLSQKRFKCAATATTGATGATGTAGTAAGATTGTCCCAGAAGAGGTTCAAACA
PTEN-HECTD2chr1089653866chr1093244264722NIDDVVRLSQKRFKQTATTGATGATGTAGTAAGATTGTCCCAGAAGAGGTTCAAACAATT
PTEN-HECTD2chr1089653866chr1093244264823IDDVVRLSQKRFKQLTGATGATGTAGTAAGATTGTCCCAGAAGAGGTTCAAACAATTGGT
PTEN-HECTD2chr1089653866chr1093244264924DDVVRLSQKRFKQLVTGATGTAGTAAGATTGTCCCAGAAGAGGTTCAAACAATTGGTAGA

Top

Information of the samples that have these potential fusion neoantigens of PTEN-HECTD2

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
PRADPTEN-HECTD2chr1089653866ENST00000371953chr1093244264ENST00000446394TCGA-HC-7748

Top

Potential target of CAR-T therapy development for PTEN-HECTD2

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to PTEN-HECTD2

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to PTEN-HECTD2

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource